OBJECTIVE	Overexpression of the excision repair cross-complementing 1 ( ERCC1 ) gene , which is crucial in the repair of cisplatin ( CDDP ) - DNA adducts , is reported to negatively influence the effectiveness of CDDP-based therapy for gastric and ovarian cancers .\